{"id":191646,"date":"2025-12-23T00:00:00","date_gmt":"2025-12-23T00:00:00","guid":{"rendered":"http:\/\/clarivate.com\/life-sciences-healthcare\/report\/47041077-medtech-diabetes-care-devices-market-insights-united\/"},"modified":"2026-03-31T10:09:18","modified_gmt":"2026-03-31T10:09:18","slug":"47042643-medtech-diabetes-care-devices-market-insights-united-states","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/47042643-medtech-diabetes-care-devices-market-insights-united-states\/","title":{"rendered":"Diabetes Care Devices &#8211; Market Insights &#8211; United States"},"content":{"rendered":"<p>The US diabetes care device market will see <span>strong growth<\/span> over the forecast period, spurred by various factors, namely\u00a0<abbr title=\"Food and Drug Administration\">FDA<\/abbr> approvals for new products with expanded indications, strong growth in the\u00a0<abbr title=\"Continuous Glucose Monitoring\">CGM<\/abbr> device segment, the growing diabetes population, and the continued innovation of devices in this sector.<\/p>\n<p>This Medtech 360 Report provides comprehensive data and analysis on the state of the diabetes care device market in the US from 2019 through 2034.<\/p>\n<p><strong>The US diabetes care device market will <span>grow strongly<\/span> through 2034.<\/strong><\/p>\n<p>How will growth vary between product segments?<\/p>\n<p>What are the factors driving market expansion?<\/p>\n<p><b>Innovation will drive growth in the US diabetes care device market.<\/b><\/p>\n<p>What are some recent technological innovations that have enhanced the capabilities of devices in this market?\u00a0<\/p>\n<p><strong>Diabetes care devices are getting approved for use by a wider range of people with type 2 diabetes.<\/strong><\/p>\n<p>Which product segments have received approvals for type 2 diabetes population?<\/p>\n<p>How will expanded approvals impact the overall market?<\/p>\n<p><strong><abbr title=\"Glucagon-Like Peptide-1\">GLP-1<\/abbr> receptor agonists have been seeing growing adoption among the US patient population in recent years.<\/strong><\/p>\n<p>How will adoption of <abbr title=\"Glucagon-Like Peptide-1\">GLP-1<\/abbr> receptor agonists affect the US diabetes care device market?<\/p>\n<p>Which market segments will be more impacted by the growing popularity of <abbr title=\"Glucagon-Like Peptide-1\">GLP-1<\/abbr> receptor agonists?<\/p>\n<p><strong>Numerous new competitors and products are expected to enter this space within the forecast period.<\/strong><\/p>\n<p>Who are these competitors and what products are they bringing to the market?<\/p>\n<p>How will the new entrants affect the existing competitive space?<\/p>\n","protected":false},"template":"","class_list":["post-191646","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-diabetes-care-devices","medtech-therapy-area-other-medical-technology","medtech-geography-united-states","medtech-date-2294"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/191646","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":3,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/191646\/revisions"}],"predecessor-version":[{"id":571863,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/191646\/revisions\/571863"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=191646"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}